Stock listing

Bb Biotech Ag

Selected listing: BION · SIX · CHF · CH

Bb Biotech Ag (SIX Swiss: BION), Finance. Latest release Jul 24, 2026: BB Biotech AG publishes its interim report and revises its dividend policy.

BION:SIXCHFCHUpdated October 2, 2026

Ticker: SIX Swiss: BION
Asset type: Stock
Sector: Finance
Industry: Financial Conglomerates
Exchange: SIX Swiss
Currency: CHF

About Bb Biotech Ag

Bb Biotech AG is a public company based in Switzerland, trading under the ticker BION. It focuses on investments in innovative biotechnology companies, aiming to drive advancements in healthcare.

Latest news from Bb Biotech Ag

BB Biotech AG publishes its interim report and revises its dividend policy

July 24, 2026

BB Biotech Q2 2026: Strong NAV outperformance driven by disciplined stock selection and portfolio positioning

July 24, 2026

BB Biotech : Interim Report (BION2026 Q1 en)

April 24, 2026

BB Biotech AG publishes its interim report

April 24, 2026

Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.25 per share

March 19, 2026

All Bb Biotech Ag news →

Events

Replays

Bb Biotech Ag Namen-Akt (BBAGF) Q4 2025 Earnings Call
Fri, Feb 20, 2026 · 04:00 AM ET
Watch

Research Bb Biotech Ag

Bb Biotech Ag company profile

View the public company page for Bb Biotech Ag on 6ix.

Bb Biotech Ag news

Read company news and market updates connected to Bb Biotech Ag.

Bb Biotech Ag investor events

Find investor webinars, events, and replay context for Bb Biotech Ag.